Effect of a novel 5-HT3 receptor agonist MKC-733 on upper gastrointestinal motility in humans.
Coleman NS, Marciani L, Blackshaw E, Wright J, Parker M, Yano T, Yamazaki S, Chan PQ, Wilde K, Gowland PA, Perkins AC, Spiller RC.
Coleman NS, et al. Among authors: gowland pa.
Aliment Pharmacol Ther. 2003 Nov 15;18(10):1039-48. doi: 10.1046/j.1365-2036.2003.01797.x.
Aliment Pharmacol Ther. 2003.
PMID: 14616171
Clinical Trial.